Functional lac carrier proteins in cytoplasmic membrane vesicles isolated from Escherichia coli. 2. Experimental evidence for a segregation of the lac carrier proteins induced by a conformational transition of the membrane lipids

Biochemistry ◽  
1977 ◽  
Vol 16 (17) ◽  
pp. 3777-3780 ◽  
Author(s):  
Lucienne Letellier ◽  
Rudolf Weil ◽  
Emanuel Shechter
2002 ◽  
Vol 184 (5) ◽  
pp. 1370-1377 ◽  
Author(s):  
Jian-Lin Yu ◽  
Leo Grinius ◽  
David C. Hooper

ABSTRACT Overexpression of NorA, an endogenous efflux transporter of Staphylococcus aureus, confers resistance to certain fluoroquinolone antimicrobials and diverse other substrates. The norA gene was amplified by PCR and cloned in the expression vector pTrcHis2. Histidine-tagged NorA (NorA-His) was overexpressed in Escherichia coli cells to prepare two experimental systems, everted membrane vesicles enriched with NorA-His and proteoliposomes reconstituted with purified NorA-His. In membrane vesicles, NorA-His actively transported Hoechst 33342, a dye that is strongly fluorescent in the membrane but has low fluorescence in an aqueous environment. Transport was activated by the addition of ATP or lactate and reversed by the addition of nigericin, with the addition of K+-valinomycin having little effect. Transport of Hoechst 33342 was inhibited competitively by verapamil, a known inhibitor of NorA, and by other NorA substrates, including tetraphenyl phosphonium and the fluoroquinolones norfloxacin and ciprofloxacin. In contrast, sparfloxacin, a fluoroquinolone whose antimicrobial activity is not affected by NorA expression, exhibited noncompetitive inhibition. NorA induction and overexpression yielded 0.5 to 1 mg of a largely homogeneous 40- to 43-kDa protein per liter of culture. NorA-His incorporated into proteoliposomes retained the ability to transport Hoechst 33342 in response to an artificial proton gradient, and transport was blocked by nigericin and verapamil. These data provide the first experimental evidence of NorA functioning as a self-sufficient multidrug transporter.


1978 ◽  
Vol 83 (1) ◽  
pp. 117-128 ◽  
Author(s):  
Ichiro YAMATO ◽  
Masamitsu FUTAI ◽  
Yasuhiro ANRAKU ◽  
Yoshiaki NONOMURA

1981 ◽  
Vol 197 (2) ◽  
pp. 283-291 ◽  
Author(s):  
A Graham

The organization of the membrane-bound hydrogenase from Escherichia coli was studied by using two membrane-impermeant probes, diazotized [125I]di-iodosulphanilic acid and lactoperoxidase-catalysed radioiodination. The labelling pattern of the enzyme obtained from labelled spheroplasts was compared with that from predominantly inside-out membrane vesicles, after recovery of hydrogenase by immunoprecipitation. The labelling pattern of F1-ATPase was used as a control for labelling at the cytoplasmic surface throughout these experiments. Hydrogenase (mol.wt. approx. 63 000) is transmembranous. Crossed immunoelectrophoresis with anti-(membrane vesicle) immunoglobulins, coupled with successive immunoadsorption of the antiserum with spheroplasts, confirmed the location of hydrogenase at the periplasmic surface. Immunoadsorption with sonicated spheroplasts suggests that the enzyme is also exposed at the cytoplasmic surface. Inside-out vesicles were prepared by agglutination of sonicated spheroplasts, and the results of immunoadsorption using these vesicles confirms the location of hydrogenase at the cytoplasmic surface.


Sign in / Sign up

Export Citation Format

Share Document